Cochrane Colloquium

Cochrane Colloquium
Name	Cochrane Colloquium
Status	Active
Frequency	Annual
First	1993
Organizer	Cochrane
Location	Rotating international venues

Cochrane Colloquium The Cochrane Colloquium is an annual international conference associated with Cochrane (organization) that convenes researchers, clinicians, policymakers, funders and patient advocates to discuss systematic reviews and evidence synthesis. Early gatherings attracted participants from institutions such as World Health Organization, National Institutes of Health (United States), European Commission, United Kingdom National Health Service, and Canadian Institutes of Health Research, shaping dialogues involving Cochrane Collaboration-affiliated networks and allied organizations like Campbell Collaboration, Global Evidence Synthesis Initiative, JBI (Joanna Briggs Institute), Alliance for Health Policy and Systems Research, and Patient-Centered Outcomes Research Institute.

History

The Colloquium originated in the early 1990s amid a surge of interest from entities including Oxford University, McMaster University, Harvard University, University of Toronto, and Karolinska Institutet in developing rigorous evidence synthesis methods. Founding figures who contributed to early meetings had connections with Iain Chalmers, Gordon Guyatt, Archie Cochrane-influenced movements, and scholars from Cochrane Collaboration nodes across United Kingdom, Australia, Canada, United States, Sweden, and Netherlands. Subsequent editions engaged stakeholders from European Medicines Agency, Food and Drug Administration, World Bank, Bill & Melinda Gates Foundation, Wellcome Trust, National Health Service (England), and academic centres such as Imperial College London, University of Oxford, Stanford University, Yale University, University of Sydney.

Purpose and Scope

The Colloquium aims to advance methodology and application of systematic reviews, meta-analysis, and guideline development, aligning with practices employed by Cochrane (organization), GRADE Working Group, PRISMA, CONSORT, and EPOC (Cochrane Effective Practice and Organisation of Care) contributors. It spans clinical interventions, public health, health policy, and allied topics intersecting with agencies like World Health Organization, UNICEF, UNAIDS, OECD, and funders such as National Institutes of Health (United States), Canadian Institutes of Health Research, Australian National Health and Medical Research Council, European Commission Horizon 2020, and Wellcome Trust.

Organization and Governance

Governance involves the Cochrane (organization) central executive alongside regional entities such as Cochrane UK, Cochrane Australia, Cochrane Canada, Cochrane South Africa, and nodes within Cochrane Central Executive. Advisory input frequently comes from committees with representatives from institutions like WHO Guidelines Review Committee, GRADE Working Group, Campbell Collaboration, Joanna Briggs Institute, International Committee of Medical Journal Editors, and stakeholder groups affiliated with World Health Organization and national agencies including National Health Service (United Kingdom), Ministry of Health (Brazil), Ministry of Health (India), Ministry of Health (South Africa). Funding and sponsorship have involved Wellcome Trust, Bill & Melinda Gates Foundation, European Commission, and university hosts such as University of Auckland, University of Barcelona, University of Cape Town, McMaster University.

Annual Meetings and Locations

Meetings rotate globally, hosted in cities linked to academic centres and health organizations, including past venues associated with Edinburgh, Vancouver, Cape Town, Seville, Sydney, Quebec City, Hyderabad, Prague, Rome, Lisbon, Singapore, Barcelona, Auckland, Seoul, and Beijing. Hosts have included collaborations with University of Edinburgh, University of British Columbia, University of Cape Town, Universidad de Sevilla, University of Sydney, Université Laval, Osmania University, Charles University, Sapienza University of Rome, University of Lisbon, National University of Singapore, Universitat de Barcelona, University of Auckland, Seoul National University, and Peking University.

Themes and Programs

Programs combine plenaries, workshops, methods symposiums, and networking sessions covering topics aligned with GRADE Working Group methods, PRISMA reporting, CONSORT trial appraisal, ROBINS-I bias assessment, QUADAS-2 diagnostic accuracy, and frameworks from EPOC and GRADE-CERQual. Sessions involve contributors from World Health Organization, European Medicines Agency, Food and Drug Administration, NICE (National Institute for Health and Care Excellence), Centers for Disease Control and Prevention, Pan American Health Organization, UNICEF, and research groups from Johns Hopkins University, Harvard T.H. Chan School of Public Health, London School of Hygiene & Tropical Medicine, Brown University, Duke University, University of Melbourne, Monash University, and University of Copenhagen.

Participation and Attendance

Attendees include systematic reviewers, clinicians, guideline developers, policy advisors, patient and public representatives, and funders from organizations like World Health Organization, European Commission, National Institutes of Health (United States), Medical Research Council (United Kingdom), Australian National Health and Medical Research Council, Wellcome Trust, Bill & Melinda Gates Foundation, alongside professional societies such as American Medical Association, Royal College of Physicians (United Kingdom), Canadian Medical Association, Australian Medical Association, and international networks like Global Health Council and International Society for Pharmacoeconomics and Outcomes Research.

Impact and Criticism

The Colloquium has influenced guideline development, methodology standards, and international collaborations involving WHO, NICE (National Institute for Health and Care Excellence), GRADE Working Group, and Campbell Collaboration, catalyzing outputs cited by Cochrane Database of Systematic Reviews, The Lancet, BMJ, JAMA, New England Journal of Medicine, and other journals. Criticisms mirror debates within evidence synthesis, voiced by stakeholders at institutions including Global Evidence Synthesis Initiative, Patient-Centered Outcomes Research Institute, and independent academics from University of Oxford, McMaster University, Harvard University regarding inclusivity, geographic representation, language barriers, and tensions between methodological rigor and policy relevance. Discussions have referenced interactions with regulatory bodies such as European Medicines Agency and Food and Drug Administration about applicability of systematic review evidence in regulatory decision-making.

Category:Conferences